Oncologist Urge FDA to Allow Cancer Patients Access to Silicone Implants, But Continue Study
In Brief: Healy to Name Jay Moskowitz Deputy Direct, Promote Mahoney To Deputy Budge Director
NCI To File Record No. Of INDS In ’92, Expand Phase 1 Trials
Advisors Ok New RFP For Natural Product Large-Scale Production
National Coalition Dinner Honors Cancer Program Founders, Advocates, And Cancer Survivors
DES Exposure Studies Below Payline; NCI Considers Contracts
ICCCR Issues RFP For Cancer Risk Scale
Trending Stories
- FDA’s second rejection of Replimune’s melanoma treatment stirs worry among oncologists, patients
“Patients are owed another review.” - Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- Mayo Clinic AI detects pancreatic cancer up to three years before diagnosis, validation study finds
- CBER Director Vinay Prasad dared to “say no to drugs”
- At AACR, Letai announces prevention and screening project for southern Appalachia, describes a future without paylines
There’s “clear evidence that funding is moving and the system is working.” - Richard Pazdur left FDA to avoid being part of “the destruction of the American medical system”









